Successful molecular targeted treatment of AML in pregnancy with Azacitidine and Sorafenib with no adverse fetal outcomes. (21st October 2016) - Mahdi, Ali J.; Gosrani, Deepan; Chakraborty, Mallinath; Rees, Alexandra; Conner, Christine; Wilson, Keith; Rayment, Rachel; Alvares, Caroline